You're using an outdated browser. Please upgrade to a modern browser for the best experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Francisco Esteban Nicolas Molina -- 2529 2022-04-01 13:47:42 |
2 format is correct Yvaine Wei Meta information modification 2529 2022-04-02 17:14:32 |

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Nicolas Molina, F.E.; Lax Molina, C.; Cánovas-Márquez, J.; Tahiri, G.; Navarro Ros, E.; Garre, V. Mucormycosis and Genetic Manipulation in Mucorales. Encyclopedia. Available online: https://encyclopedia.pub/entry/21281 (accessed on 23 December 2025).
Nicolas Molina FE, Lax Molina C, Cánovas-Márquez J, Tahiri G, Navarro Ros E, Garre V. Mucormycosis and Genetic Manipulation in Mucorales. Encyclopedia. Available at: https://encyclopedia.pub/entry/21281. Accessed December 23, 2025.
Nicolas Molina, Francisco Esteban, Carlos Lax Molina, José Cánovas-Márquez, Ghizlane Tahiri, Eusebio Navarro Ros, Victoriano Garre. "Mucormycosis and Genetic Manipulation in Mucorales" Encyclopedia, https://encyclopedia.pub/entry/21281 (accessed December 23, 2025).
Nicolas Molina, F.E., Lax Molina, C., Cánovas-Márquez, J., Tahiri, G., Navarro Ros, E., & Garre, V. (2022, April 01). Mucormycosis and Genetic Manipulation in Mucorales. In Encyclopedia. https://encyclopedia.pub/entry/21281
Nicolas Molina, Francisco Esteban, et al. "Mucormycosis and Genetic Manipulation in Mucorales." Encyclopedia. Web. 01 April, 2022.
Mucormycosis and Genetic Manipulation in Mucorales
Edit
This entry is adapted from the peer-reviewed paper 10.3390/ijms23073454

The emerging fungal infection caused by Mucorales is known as mucormycosis. The main reasons for this current attraction to study mucormycosis are its high lethality, the lack of effective antifungal drugs, and its recent increased incidence. The most contemporary example of the emergence character of mucormycosis is the epidemics declared in several Asian countries as a direct consequence of the COVID-19 pandemic. 

mucormycosis virulence Mucorales homologous recombination genetic models Mucor lusitanicus Rhizopus microsporus CRISPR-Cas9

1. Introduction

Mucorales are a group of early-diverging fungi with many distinct and unique features. One of the most prominent and beautiful features of some Mucorales is their response to light, producing carotenoids and showing a pronounced phototropism [1]. Their unusual and striking reactions to changes in the environment caught the attention of researchers in the beginnings of the first genetic studies. Among those researchers, the Nobel-awarded Max Delbrück dedicated more than 25 years studying the sensory perception in a simple cell using Phycomyces blakesleeanus as a model for more complex sensory systems. He believed that this fungus would become an essential model to develop the discipline of molecular biology and understand the interaction of an organism with its environment, the perception of information, the analysis of such information, and its corresponding responses. He also set the trend for many other researchers that continued his work. At that time, many researchers used the classic genetic methodologies (mutagenesis, phenotype selection, and mating analyses) to study the genetic regulation of these fungal responses [2]. However, the advances of this new mucoralean research community were soon hampered by another striking feature of Mucorales: their common reluctance to be genetically transformed [3]. This unconquerable disadvantage motivated many researchers to move their molecular studies to other fungal models with efficient genetic manipulation tools such as Saccharomyces, Candida, and Aspergillus [4][5].
The interest to study Mucorales increased at the end of the first decade of this century because of the renewed emergence of the fungal infectious disease known as mucormycosis. Mucormycosis is a lethal disease caused by several mucoralean species, being the most frequent among the genus Rhizopus, followed by Mucor and Lichtheimia (formerly Absidia) [6][7][8]. In the past, Mucormycosis was considered a rare infection related to immunosuppressed and otherwise compromised patients. However, new clinical reports and improvements in the correct diagnosis of mucormycosis have shown an emerging increase in the number of cases [9][10]. Indeed, the increased incidence of mucormycosis in COVID-19 patients associated with corticosteroid treatment has raised the scientific and clinical community’s concerns about treating infections caused by the so-named “black fungus” [11][12]. More importantly, some reports also describe an escalating number of mucormycosis cases in healthy patients without known predisposing diseases [13][14].
Furthermore, mucormycosis has mortality rates that can reach up to 90% in the cases of bloodstream disseminated infection [15][16]. These high mortality rates are mainly due to the innate antifungal drug resistance observed in Mucorales, which leaves clinicians with a few poorly effective treatments against mucormycosis [8][17][18][19][20][21]. Besides their natural high antifungal drug resistance, Mucorales can rapidly acquire new antifungal drug resistances through an exclusive RNAi-based mechanism to fast and temporally generate resistant epimutants [22]. In this sense, most of the current studies in Mucorales are focused on investigating new genes, pathways, methodologies, and virulence factors that might be the targets for future antifungal developments against mucormycosis [23][24][25][26][27][28][29][30][31][32]. However, this renewed interest in mucormycosis studies is still hampered by the few modern genetic tools available in Mucorales.
The general reluctance of Mucorales to genetic manipulation has limited the genetic dissection of mucormycosis to the fungal model Mucor lusitanicus, previously known as Mucor circinelloides f. lusitanicus [33]. Homologous recombination was possible only in M. lusitanicus, which also allows other genetic tools such as genetic complementation, directed mutagenesis, and tag labeling [23][34][35][36]. These methodologies were used to dissect several genetic mechanisms in Mucorales, including the light responses, the RNAi mechanism, and more recently, the virulence of Mucorales. However, M. lusitanicus is not virulent without a strongly immunosuppressed host and an unnaturally high dose of spores in the initial injection [37][38] limitations to genetic studies on pathogenic Mucorales have been recently overcome with a new methodology to transform the fungus Rhizopus microsporus, an actual mucormycosis agent frequently isolated from patients [39].

2. Mucor lusitanicus, the Primary Genetic Model in Mucorales

The historical reluctance of Mucorales to genetic manipulation hampered the research of this group of fungi as model organisms. However, they are easily cultured under laboratory conditions and exhibit fast-growing and apparent phenotypes to study many biological processes. The classical model organism of Mucorales was Phycomyces blakesleeanus, to which Delbrück dedicated more than two decades studying the interaction of this model organism with the environment. Unfortunately, its inability to be transformed with exogenous DNA forced many researchers to explore other models [40]. The early development of an efficient transformation method of M. lusitanicus based on self-replicative plasmids [41] laid the foundation of this fungus as the primary genetic model in Mucorales [42]. This early transformation technique, based on polyethylene glycol (PEG) to allow the DNA entry into protoplast, has been refined all over the years until the successful implementation of the electroporation protocol [43]. Thenceforth, the genetic tools to manipulate the genome of M. lusitanicus have grown exponentially, allowing the characterization of the response to light [44][45], RNA interference (RNAi) [46], pathogenesis [23][32], lipids metabolism [47], carotenoids biosynthesis, centromere structure, and dimorphism [36][45][48][49][50].

2.1. Plasmid Transformation, RNAi, and Functional Genomics

M. lusitanicus transformation complements auxotrophic markers such as leucine, uracil, and methionine. The obtention of auxotrophs [51] and the characterization of the genes that complement these phenotypes [41][52] allowed their use as selectable markers. Thus, the inclusion of the selectable markers in self-replicative plasmids entailed the development of the first molecular tools in M. lusitanicus.
Using these selectable self-replicative plasmids as recipients to construct genomic libraries boosted the characterization of the carotenoid’s biosynthetic pathway. The filamentous fungus M. lusitanicus exhibits a yellow phenotype cultured under illumination conditions due to the accumulation of β-carotene as other Mucorales. Before discovering RNAi in M. lusitanicus, the implementation of genomic libraries and an accidentally silenced dark-yellow transformant led to the identification of a gene involved in the process of carotenogenesis, the negative regulator crgA [49]. This discovery led to the further complete dissection of the silencing mechanism in M. lusitanicus [26][53][54][55][56].

2.2. Homologous Recombination and Its Derived Genetic Tools in M. lusitanicus

The use of self-replicative plasmids supposed the beginning of the genetic tools that placed M. lusitanicus in a unique position as a model organism. However, the true landmark in the genetics of Mucorales was the development of a methodology to edit the genome of M. lusitanicus by homologous recombination [49]. From gene disruption to the most recent protein-tagging strategies, the use of the homologous recombination phenomenon supposed a revolution that converted this fungus into a reference model for genetic manipulation.
The first studies reporting homologous recombination in M. lusitanicus appeared right after the development of the transformation method [41][57]. The homologous recombination process supposes the reparation of a double-strand break (DSB) in the DNA by using a similar or identical DNA molecule to replace the region affected [58]. The observation of this process in self-replicative plasmids supposed the first hint indicating that the natural occurrence of DSB was frequent enough for applying it to develop a genome-edition method in M. lusitanicus [57][59].

3. Rhizopus microsporus, the New Genetic Model to Study Mucormycosis

Among all Mucorales, R. microsporus combines several characteristics that make it one of the most interesting species. This fungus is a model for studying symbiotic relationships between fungi and bacteria [60]. While some strains of R. microsporus can complete sexual and asexual reproduction independently, others require bacteria to reproduce [60]. Thus, R. microsporus is a well-known model of mutualistic symbiosis that may have evolved from a previous antagonistic interaction [61][62]. Moreover, this fungus is also a plant pathogen, causing rice seedling blight [63]. Symbiotic bacteria (Mycetohabitans sp., previously classified as Burkholderia) produce rhizoxin, a toxin that blocks plant mitosis and allows both fungus and bacteria to live in the necrotized plant tissue [63].
Bacterial presence and rhizoxin production are not essential for developing the lethal disease mucormycosis [64]. Infection caused by Rhizopus species supposes around 50% of all cases reported of this disease globally, being the most prevalent genus among all causal fungal agents of mucormycosis [14]. Along with Mucor, some mechanisms involved in the pathogenesis of mucormycosis have been unraveled in Rhizopus. For instance, macrophages are the first line of defense against the infection, and iron restriction inside the phagosomes regulates host defense [25][65]. In addition, the endothelial CotH proteins are a crucial element in the adhesion and invasion of the tissues [24].

3.1. A New R. microsporus Strain for Genetic Transformation: Auxotrophic Isolation and Plasmid Transformation

Undoubtedly, tools that allow for genetic manipulation open many possibilities. Given the limitations and the difficulties associated with genetic modification of Mucorales, a step-by-step optimization of the process was necessary to achieve this complex and longed-for goal. Analogously to previous studies, a uracil auxotrophic strain of R. microsporus (ATCC 11559) was isolated [39]. However, unlike previous approaches, the R. microsporus auxotrophic strain was isolated spontaneously without mutagenic compounds or UV light [39]. This reduced mutational burden is desirable considering that this strain (UM1) will be used for downstream analysis and characterization, especially virulence assays. This strain carries a non-synonymous substitution in the pyrF gene that changes a lysine residue in the active center for a glutamic acid residue (K73E) [39].

3.2. Development of a Stable Homologous Recombination Strategy Based on the CRISPR-Cas9 Machinery in R. microsporus

Although plasmid transformation is a relevant landmark itself, the main concern with self-replicative plasmid is that only a variable proportion of descendant spores will carry the plasmid through growth cycles [34].In addition, for applications like RNAi-induced silencing, only descendants with a high copy number of plasmid can trigger silencing mechanisms [34]. The benefits and possibilities that a working genetic modification procedure by homologous recombination can produce have been previously detailed with M. lusitanicus. To combine these advantages with the virulent nature of R. microsporus, efforts focused on developing an equivalent procedure in this fungus. The successful strategy comprised using in vitro assembled ribonucleoprotein complex by Cas9 and a guide RNA (gRNA) that targets a specific sequence in the genome coupled with DNA templates flanked with micro-homology repair regions (35–40 bp). These short homology regions were adapted from the previously validated strategy developed in other fungi, like Aspergillus fumigatus [66].

3.3. Uracil Auxotrophy Is Directly Related to the Virulence of R. microsporus

As a proof of concept, the wild-type R. microsporus strain, the uracil auxotrophic strain (pyrF−), and the pyrF complemented strains (with pyrF gene integrated either in leuA and crgA locus) were tested in mice infection experiments. In contrast with mice infection experiments with M. lusitanicus, which require strong immunosuppression and the use of specific mouse strain, R. microsporus shows an apparent virulence with immunocompetent Swiss mice [39]. While the wild-type strain of R. microsporus killed all mice in the first 6-7 days post-infection, the pyrF− strain did not kill any mice, showing an utterly avirulent phenotype. The virulent phenotype was restored in the leuA and crgA mutant strains when they integrated a functional copy of pyrF gene [39]. Consistent with findings in other fungi, uracil autotrophy has also been determined as a virulence trait in A. fumigatus and Candida albicans [67][68][69].

4. Attempts to Transform Other Mucorales

4.1. Homologous Recombination in Rhizopus delemar

Rhizopus delemar (previously known as R. oryzae) is one of the most frequent causal agents isolated from patients suffering mucormycosis [70]. However, genetic manipulation in R. delemar, is quite limited. The aseptate hyphae, the multinucleated vegetative spores, and the duplicated genome are mucoralean features influencing the inefficient generation of stable null mutants [71]. The principal attempt to study a gene function in R. delemar was in the high-affinity iron uptake system by gene disruption of one of its components. Iron is an essential micronutrient for all microorganisms, and during infection, pathogenic microbes must obtain it from the host, making it an interesting target for antifungal treatments. In R. delemar, the high-affinity iron uptake system has three key elements: an iron reductase (FRE), a ferroxidase (FET3), and a permease (FTR1). A disruption approach was designed more than a decade ago using the auxotrophy marker pyrF flanked by two homology fragments for homologous recombination in the ftr1 locus. The result of this study was an unstable heterokaryon mutant, which was interpreted as evidence of the essential role of this gene in Mucorales. However, further studies demonstrated that this gene could be easily disrupted in M. lusitanicus [32].

4.2. CRISPR-Cas9-Based Mutagenesis in the Fungus Lichtheimia corymbifera

L. corymbifera is another causal agent of mucormycosis presenting a high isolation frequency from clinical samples right after R. delemar [14]. Like other Mucorales, L. corymbifera also strongly resists the traditional genetic manipulation methodologies. The lack of genetic tools has hampered the dissection of the genetic pathways behind the pathogenic potential of L. corymbifera. Homologous recombination using exogenous DNA fragments has not been achieved in L. corymbifera, not even in an unstable state like in R. delemar. However, an adapted methodology based on the CRISPR-Cas9 system and without the necessity of an autoreplicative plasmid worked in L. corymbifera to disrupt a target locus [72]. This plasmid-free system directly transformed the L. corymbifera protoplasts with the Cas9 protein and two guides RNAs (gRNA) flanking a region of the uracil selective marker gene pyrG (encoding the orotidine 5′-phosphate decarboxylase).

5. Conclusions

Regarding the pathogenesis of Mucorales, M. lusitanicus has been the primary genetic model during the last decade [29]. The first studies linked the size of the spore and the germination velocity with virulence [37]. A genomic platform based on the RNAi mechanism identified new genes involved in virulence [23]. The primary study of the RNAi mechanism in M. lusitanicus led to discovering an antifungal drug resistance mechanism conserved only in Mucorales based on the generation of resistant epimutants [22][26][56][73][74][75]. The high-affinity iron uptake system, an essential process in the virulence of most pathogens, was also genetically studied in M. lusitanicus [32]. Different genomic and transcriptomic approaches identified gene profiles related to virulence, and many genes from these profiles were mutated and functionally validated in survival assays [25][28]. In addition, the study of the transduction pathways in M. lusitanicus led to identifying new genes and pathways related to virulence [76][77]. Thus, M. lusitanicus has been an invaluable genetic model in studying genes and pathways associated with the virulence of Mucorales.
However, M. lusitanicus shows reduced virulence in the survival assays performed in the laboratory using murine models, and more striking, it has never been isolated from a patient as a causal agent of mucormycosis [37]. The recent development of the methodologies allowing stable homologous recombination in R. microsporus, one of the most usual causal agents of mucormycosis, represents a landmark in the study of mucormycosis. This development will make Rhizopus microsporus the leading choice for all future studies related to virulence. These recent studies showed the possibility of disrupting genes and later complementing the mutations with two different auxotrophy marker genes. The possibility of performing homologous recombination in R. microsporus predicts that other genetic techniques will soon be developed in this fungus, such as directed mutagenesis and aminoacid substitutions, overexpression, tag-labeling, and RNAi. Current and future techniques, the virulent wild type strain (positive control) and the avirulent uracil auxotrophic strain (negative control), constitute the perfect platform to study the pathogenic potential of Mucorales. Finally, the new methodology employed in transforming R. microsporus using the CRISPR-Cas technology will likely be exported to other Mucorales.

References

  1. Cerdá-Olmedo, E. Phycomyces and the biology of light and color. FEMS Microbiol. Rev. 2001, 25, 503–512.
  2. Cerda-Olmedo, E.; Lipson, E. Phycomyces; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, USA, 1987.
  3. Obraztsova, I.N.; Prados, N.; Holzmann, K.; Avalos, J.; Cerdá-Olmedo, E. Genetic damage following introduction of DNA in Phycomyces. Fungal Genet. Biol. 2003, 41, 168–180.
  4. Campbell, E.I.; Unkles, S.E.; Macro, J.A.; Hondel, C.V.D.; Contreras, R.; Kinghorn, J.R. Improved transformation efficiency of Aspergillus niger using the homologous niaD gene for nitrate reductase. Curr. Genet. 1989, 16, 53–56.
  5. Kawai, S.; Hashimoto, W.; Murata, K. Transformation of Saccharomyces cerevisiae and other fungi: Methods and possible underlying mechanism. Bioeng. Bugs 2010, 1, 395–403.
  6. Alvarez, E.; Sutton, D.A.; Cano, J.; Fothergill, A.W.; Stchigel, A.; Rinaldi, M.G.; Guarro, J. Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States. J. Clin. Microbiol. 2009, 47, 1650–1656.
  7. Roden, M.M.; Zaoutis, T.E.; Buchanan, W.L.; Knudsen, T.A.; Sarkisova, T.A.; Schaufele, R.L.; Sein, M.; Sein, T.; Chiou, C.C.; Chu, J.H.; et al. Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases. Clin. Infect. Dis. 2005, 41, 634–653.
  8. Cornely, O.A.; Alastruey-Izquierdo, A.; Arenz, D.; Chen, S.C.A.; Dannaoui, E.; Hochhegger, B.; Hoenigl, M.; Jensen, H.E.; Lagrou, K.; Lewis, R.E.; et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect. Dis. 2019, 19, e405–e421.
  9. Chayakulkeeree, M.; Ghannoum, M.A.; Perfect, J.R. Zygomycosis: The re-emerging fungal infection. Eur. J. Clin. Microbiol. 2006, 25, 215–229.
  10. Kontoyiannis, D.P. Antifungal Resistance: An Emerging Reality and A Global Challenge. J. Infect. Dis. 2017, 216, S431–S435.
  11. Veisi, A.; Bagheri, A.; Eshaghi, M.; Rikhtehgar, M.H.; Kanavi, M.R.; Farjad, R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur. J. Ophthalmol. 2021.
  12. John, T.; Jacob, C.; Kontoyiannis, D. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J. Fungi 2021, 7, 298.
  13. Sridhara, S.R.; Paragache, G.; Panda, N.K.; Chakrabarti, A. Mucormycosis in Immunocompetent Individuals: An Increasing Trend. J. Otolaryngol. 2005, 34, 402–406.
  14. Prakash, H.; Chakrabarti, A. Global Epidemiology of Mucormycosis. J. Fungi 2019, 5, 26.
  15. Jeong, W.; Keighley, C.; Wolfe, R.; Lee, W.L.; Slavin, M.A.; Kong, D.C.M.; Chen, S.C.-A. The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports. Clin. Microbiol. Infect. 2019, 25, 26–34.
  16. Hassan, M.A.; Voigt, K. Pathogenicity patterns of mucormycosis: Epidemiology, interaction with immune cells and virulence factors. Med Mycol. 2019, 57, S245–S256.
  17. Dannaoui, E. Antifungal resistance in mucorales. Int. J. Antimicrob. Agents 2017, 50, 617–621.
  18. Caramalho, R.; Tyndall, J.D.A.; Monk, B.C.; Larentis, T.; Lass-Flörl, C.; Lackner, M. Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase. Sci. Rep. 2017, 7, 15898.
  19. Caetano, L.A.; Faria, T.; Springer, J.; Loeffler, J.; Viegas, C. Antifungal-resistant Mucorales in different indoor environments. Mycology 2019, 10, 75–83.
  20. Luo, G.; Gebremariam, T.; Lee, H.; French, S.W.; Wiederhold, N.; Patterson, T.F.; Filler, S.G.; Ibrahim, A.S. Efficacy of Liposomal Amphotericin B and Posaconazole in Intratracheal Models of Murine Mucormycosis. Antimicrob. Agents Chemother. 2013, 57, 3340–3347.
  21. Maurer, E.; Binder, U.; Sparber, M.; Lackner, M.; Caramalho, R.; Lass-Flörl, C. Susceptibility profiles of amphotericin B and posaconazole against clinically relevant Mucorales species under hypoxic conditions. Antimicrob. Agents Chemother. 2015, 59, 1344–1346.
  22. Calo, S.; Shertz-Wall, C.; Lee, S.C.; Bastidas, R.J.; Nicolas, F.E.; Granek, J.A.; Mieczkowski, P.; Torres-Martínez, S.; Ruiz-Vázquez, R.M.; Cardenas, M.E.; et al. Antifungal drug resistance evoked via RNAi-dependent epimutations. Nature 2014, 513, 555–558.
  23. Trieu, T.A.; Navarro-Mendoza, M.I.; Perez-Arques, C.; Sanchis, M.; Capilla, J.; Navarro-Rodríguez, P.; Lopez-Fernandez, L.; Torres-Martínez, S.; Garre, V.; Ruiz-Vázquez, R.M.; et al. RNAi-Based Functional Genomics Identifies New Virulence Determinants in Mucormycosis. PLoS Pathog. 2017, 13, e1006150.
  24. Gebremariam, T.; Alkhazraji, S.; Soliman, S.S.M.; Gu, Y.; Jeon, H.H.; Zhang, L.; French, S.W.; Stevens, D.A.; Edwards, J.E.; Filler, S.G.; et al. Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis. Sci. Adv. 2019, 5, eaaw1327.
  25. Pérez-Arques, C.; Navarro-Mendoza, M.I.; Murcia, L.; Lax, C.; Martínez-García, P.; Heitman, J.; Nicolás, F.E.; Garre, V. Mucor circinelloides Thrives inside the Phagosome through an Atf-Mediated Germination Pathway. mBio 2019, 10, 02765-18.
  26. Pérez-Arques, C.; Navarro-Mendoza, M.; Murcia, L.; Navarro, E.; Garre, V.; Nicolás, F. The RNAi Mechanism Regulates a New Exonuclease Gene Involved in the Virulence of Mucorales. Int. J. Mol. Sci. 2021, 22, 2282.
  27. Pérez-Arques, C.; Navarro-Mendoza, M.; Murcia, L.; Lax, C.; Sanchis, M.; Capilla, J.; Navarro, E.; Garre, V.; Nicolás, F. A Mucoralean White Collar-1 Photoreceptor Controls Virulence by Regulating an Intricate Gene Network during Host Interactions. Microorganisms 2021, 9, 459.
  28. López-Fernández, L.; Sanchis, M.; Navarro-Rodríguez, P.; Nicolás, F.E.; Silva-Franco, F.; Guarro, J.; Garre, V.; Navarro-Mendoza, M.I.; Pérez-Arques, C.; Capilla, J. Understanding Mucor circinelloides pathogenesis by comparative genomics and phenotypical studies. Virulence 2018, 9, 707–720.
  29. Lax, C.; Pérez-Arques, C.; Navarro-Mendoza, M.I.; Cánovas-Márquez, J.T.; Tahiri, G.; Pérez-Ruiz, J.A.; Osorio-Concepción, M.; Murcia-Flores, L.; Navarro, E.; Garre, V.; et al. Genes, pathways, and mechanisms involved in the virulence of mucorales. Genes 2020, 11, 317.
  30. Binder, U.; Navarro-Mendoza, M.I.; Naschberger, V.; Bauer, I.; Nicolas, F.E.; Pallua, J.D.; Lass-Flörl, C.; Garre, V. Generation of a mucor circinelloides reporter strain—A promising new tool to study antifungal drug efficacy and mucormycosis. Genes 2018, 9, 613.
  31. López-Muñoz, A.; Nicolás, F.E.; García-Moreno, D.; Pérez-Oliva, A.B.; Navarro-Mendoza, M.I.; Oñate, M.; Herrera-Estrella, A.; Torres-Martínez, S.; Ruiz-Vázquez, R.M.; Garre, V.; et al. An Adult Zebrafish Model Reveals that Mucormycosis Induces Apoptosis of Infected Macrophages. Sci. Rep. 2018, 8, 12.
  32. Navarro-Mendoza, M.I.; Pérez-Arques, C.; Murcia, L.; Martínez-García, P.; Lax, C.; Sanchis, M.; Capilla, J.; Nicolás, F.E.; Garre, V. Components of a new gene family of ferroxidases involved in virulence are functionally specialized in fungal dimorphism. Sci. Rep. 2018, 8, 76.
  33. Wagner, L.; Stielow, J.; De Hoog, G.; Bensch, K.; Schwartze, V.U.; Voigt, K.; Alastruey-Izquierdo, A.; Kurzai, O.; Walther, G. A new species concept for the clinically relevant Mucor circinelloides complex. Persoonia Mol. Phylogeny Evol. Fungi 2020, 44, 67–97.
  34. Nicolas, F.E.; Torres-Martínez, S.; Ruiz-Vázquez, R.M. Two classes of small antisense RNAs in fungal RNA silencing triggered by non-integrative transgenes. EMBO J. 2003, 22, 3983–3991.
  35. Trieu, T.A.; Calo, S.; Nicolas, F.E.; Vila, A.; Moxon, S.; Dalmay, T.; Torres-Martínez, S.; Garre, V.; Ruiz-Vázquez, R.M. A Non-canonical RNA Silencing Pathway Promotes mRNA Degradation in Basal Fungi. PLoS Genet. 2015, 11, e1005168.
  36. Navarro-Mendoza, M.I.; Pérez-Arques, C.; Panchal, S.; Nicolás, F.E.; Mondo, S.J.; Ganguly, P.; Pangilinan, J.; Grigoriev, I.V.; Heitman, J.; Sanyal, K.; et al. Early Diverging Fungus Mucor circinelloides Lacks Centromeric Histone CENP-A and Displays a Mosaic of Point and Regional Centromeres. Curr. Biol. 2019, 29, 3791–3802.e6.
  37. Li, C.H.; Cervantes, M.; Springer, D.J.; Boekhout, T.; Ruiz-Vazquez, R.M.; Torres-Martinez, S.R.; Heitman, J.; Lee, S.C. Sporangiospore Size Dimorphism Is Linked to Virulence of Mucor circinelloides. PLoS Pathog. 2011, 7, e1002086.
  38. Valle-Maldonado, M.I.; Patiño-Medina, J.A.; Pérez-Arques, C.; Reyes-Mares, N.Y.; Jácome-Galarza, I.E.; Ortíz-Alvarado, R.; Vellanki, S.; Ramírez-Díaz, M.I.; Lee, S.C.; Garre, V.; et al. The heterotrimeric G-protein beta subunit Gpb1 controls hyphal growth under low oxygen conditions through the protein kinase A pathway and is essential for virulence in the fungus Mucor circinelloides. Cell. Microbiol. 2020, 22, e13236.
  39. Lax, C.; Navarro-Mendoza, M.I.; Pérez-Arques, C.; Navarro, E.; Nicolás, F.E.; Garre, V. Stable and reproducible homologous recombination enables CRISPR-based engineering in the fungus Rhizopus microsporus. Cell Rep. Methods 2021, 100124.
  40. Hodgkin, J. The model organism diaspora. Heredity 2019, 123, 14–17.
  41. van Heeswijck, R.; Roncero, M.I.G. High frequency transformation of Mucor with recombinant plasmid DNA. Carlsberg Res. Commun. 1984, 49, 691–702.
  42. Vellanki, S.; Navarro-Mendoza, M.I.; Garcia, A.; Murcia, L.; Pérez-Arques, C.; Garre, V.; Nicolas, F.E.; Lee, S.C. Mucor circinelloides: Growth, Maintenance, and Genetic Manipulation. Curr. Protoc. Microbiol. 2018, 49, e53.
  43. Gutiérrez, A.; López-García, S.; Garre, V. High reliability transformation of the basal fungus Mucor circinelloides by electroporation. J. Microbiol. Methods 2011, 84, 442–446.
  44. Silva, F.; Torres-Martinez, S.; Garre, V. Distinct white collar-1 genes control specific light responses in Mucor circinelloides. Mol. Microbiol. 2006, 61, 1023–1037.
  45. Silva, F.; Navarro, E.; Peñaranda, A.; Murcia-Flores, L.; Torres-Martínez, S.; Garre, V. A RING-finger protein regulates carotenogenesis via proteolysis-independent ubiquitylation of a White Collar-1-like activator. Mol. Microbiol. 2008, 70, 1026–1036.
  46. Torres-Martínez, S.; Ruiz-Vázquez, R.M. RNAi pathways in Mucor: A tale of proteins, small RNAs and functional diversity. Fungal. Genet. Biol. 2016, 90, 44–52.
  47. Zhao, L.; Cánovas-Márquez, J.T.; Tang, X.; Chen, H.; Chen, Y.Q.; Chen, W.; Garre, V.; Song, Y.; Ratledge, C. Role of malate transporter in lipid accumulation of oleaginous fungus Mucor circinelloides. Appl. Microbiol. Biotechnol. 2016, 100, 1297–1305.
  48. Lee, S.C.; Li, A.; Calo, S.; Heitman, J. Calcineurin Plays Key Roles in the Dimorphic Transition and Virulence of the Human Pathogenic Zygomycete Mucor circinelloides. PLoS Pathog. 2013, 9, e1003625.
  49. Navarro, E.; Lorca-Pascual, J.; Quiles-Rosillo, M.; Nicolas, F.; Garre, V.; Torres-Martínez, S.; Ruiz-Vázquez, R. A negative regulator of light-inducible carotenogenesis in Mucor circinelloides. Mol. Genet. Genom. 2001, 266, 463–470.
  50. Zhang, Y.; Navarro, E.; Cánovas-Márquez, J.T.; Almagro, L.; Chen, H.; Chen, Y.Q.; Zhang, H.; Torres-Martínez, S.; Chen, W.; Garre, V. A new regulatory mechanism controlling carotenogenesis in the fungus Mucor circinelloides as a target to generate β-carotene over-producing strains by genetic engineering. Microb. Cell Factories 2016, 15, 1–14.
  51. Roncero, M.I.G. Enrichment method for the isolation of auxotrophic mutants of Mucor using the polyene antibiotic N-glycosyl-polifungin. Carlsberg Res. Commun. 1984, 49, 685–690.
  52. Anaya, N.; Roncero, M.I.G. Transformation of a methionine auxotrophic mutant of Mucor circinelloides by direct cloning of the corresponding wild type gene. MGG Mol. Gen. Genet. 1991, 230, 449–455.
  53. Nicolás, F.E.; Ruiz-Vázquez, R.M. Functional Diversity of RNAi-Associated sRNAs in Fungi. Int. J. Mol. Sci. 2013, 14, 15348–15360.
  54. Ruiz-Vázquez, R.M.; Nicolás, F.E.; Torres-Martínez, S.; Garre, V. Distinct RNAi Pathways in the Regulation of Physiology and Development in the Fungus Mucor circinelloides. Adv. Genet. 2015, 91, 55–102.
  55. Cánovas-Márquez, J.; Navarro-Mendoza, M.; Pérez-Arques, C.; Lax, C.; Tahiri, G.; Pérez-Ruiz, J.; Lorenzo-Gutiérrez, D.; Calo, S.; López-García, S.; Navarro, E.; et al. Role of the Non-Canonical RNAi Pathway in the Antifungal Resistance and Virulence of Mucorales. Genes 2021, 12, 586.
  56. Pérez-Arques, C.; Navarro-Mendoza, M.I.; Murcia, L.; Navarro, E.; Garre, V.; Nicolás, F.E. A non-canonical RNAi pathway controls virulence and genome stability in Mucorales. PLoS Genet. 2020, 16, e1008611.
  57. Arnau, J.; Jepsen, L.P.; Strømani, P. Integrative transformation by homologous recombination in the zygomycete Mucor circinelloides. Mol. Gen. Genet. MGG 1991, 225, 193–198.
  58. Thompson, L.H.; Schild, D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res. Mol. Mech. Mutagen. 2001, 477, 131–153.
  59. Arnau, J.; Strøman, P. Gene replacement and ectopic integration in the zygomycete Mucor circinelloides. Curr. Genet. 1993, 23, 542–546.
  60. Mondo, S.J.; Lastovetsky, O.; Gaspar, M.L.; Schwardt, N.H.; Barber, C.C.; Riley, R.; Sun, H.; Grigoriev, I.V.; Pawlowska, T.E. Bacterial endosymbionts influence host sexuality and reveal reproductive genes of early divergent fungi. Nat. Commun. 2017, 8, 1–9.
  61. Lastovetsky, O.A.; Gaspar, M.L.; Mondo, S.J.; LaButti, K.M.; Sandor, L.; Grigoriev, I.V.; Henry, S.A.; Pawlowska, T.E. Lipid metabolic changes in an early divergent fungus govern the establishment of a mutualistic symbiosis with endobacteria. Proc. Natl. Acad. Sci. USA 2016, 113, 15102–15107.
  62. Aanen, D.K.; Hoekstra, R.F. The evolution of obligate mutualism: If you can’t beat ’em, join ’em. Trends Ecol. Evol. 2007, 22, 506–509.
  63. Partida-Martinez, L.P.; Hertweck, C. Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature 2005, 437, 884–888.
  64. Ibrahim, A.S.; Gebremariam, T.; Liu, M.; Chamilos, G.; Kontoyiannis, D.P.; Mink, R.; Kwon-Chung, K.J.; Fu, Y.; Skory, C.D.; Edwards, J.E., Jr.; et al. Bacterial Endosymbiosis Is Widely Present among Zygomycetes but Does Not Contribute to the Pathogenesis of Mucormycosis. J. Infect. Dis. 2008, 198, 1083–1090.
  65. Nicolás, F.E.; Murcia, L.; Navarro, E.; Navarro-Mendoza, M.I.; Pérez-Arques, C.; Garre, V. Mucorales Species and Macrophages. J. Fungi 2020, 6, 94.
  66. Al Abdallah, Q.; Ge, W.; Fortwendel, J.R. A Simple and Universal System for Gene Manipulation in Aspergillus fumigatus: In Vitro -Assembled Cas9-Guide RNA Ribonucleoproteins Coupled with Microhomology Repair Templates. mSphere 2017, 2, e00446-17.
  67. D’Enfert, C.; Diaquin, M.; Delit, A.; Wuscher, N.; Debeaupuis, J.P.; Huerre, M.; Latge, J.P. Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus. Infect. Immun. 1996, 64, 4401–4405.
  68. Bain, J.M.; Stubberfield, C.; Gow, N.A.R. Ura-status-dependent adhesion of Candida albicans mutants. FEMS Microbiol. Lett. 2006, 204, 323–328.
  69. Brand, A.; MacCallum, D.M.; Brown, A.J.P.; Gow, N.A.R.; Odds, F.C. Ectopic Expression of URA3 Can Influence the Virulence Phenotypes and Proteome of Candida albicans but Can Be Overcome by Targeted Reintegration of URA3 at the RPS10 Locus. Eukaryot. Cell 2004, 3, 900–909.
  70. Petrikkos, G.; Skiada, A.; Lortholary, O.; Roilides, E.; Walsh, T.J.; Kontoyiannis, D.P. Epidemiology and Clinical Manifestations of Mucormycosis. Clin. Infect. Dis. 2012, 54 (Suppl. 1), S23–S34.
  71. Ma, L.-J.; Ibrahim, A.S.; Skory, C.; Grabherr, M.G.; Burger, G.; Butler, M.; Elias, M.; Idnurm, A.; Lang, B.F.; Sone, T.; et al. Genomic Analysis of the Basal Lineage Fungus Rhizopus oryzae Reveals a Whole-Genome Duplication. PLoS Genet. 2009, 5, e1000549.
  72. Ibragimova, S.; Szebenyi, C.; Sinka, R.; Alzyoud, E.I.; Homa, M.; Vágvölgyi, C.; Nagy, G.; Papp, T. CRISPR-Cas9-Based Mutagenesis of the Mucormycosis-Causing Fungus lichtheimia corymbifera. Int. J. Mol. Sci. 2020, 21, 3727.
  73. Calo, S.; Nicolás, F.E.; Lee, S.C.; Vila, A.; Cervantes, M.; Torres-Martinez, S.; Ruiz-Vazquez, R.M.; Cardenas, M.E.; Heitman, J. A non-canonical RNA degradation pathway suppresses RNAi-dependent epimutations in the human fungal pathogen Mucor circinelloides. PLoS Genet. 2017, 13, e1006686.
  74. Chang, Z.; Heitman, J. Drug-Resistant Epimutants Exhibit Organ-Specific Stability and Induction during Murine Infections Caused by the Human Fungal Pathogen Mucor circinelloides. mBio 2019, 10.
  75. Chang, Z.; Billmyre, R.B.; Lee, S.C.; Heitman, J. Broad antifungal resistance mediated by RNAi-dependent epimutation in the basal human fungal pathogen Mucor circinelloides. PLoS Genet. 2019, 15, e1007957.
  76. Patiño-Medina, J.A.; Maldonado-Herrera, G.; Pérez-Arques, C.; Alejandre-Castañeda, V.; Reyes-Mares, N.Y.; Valle-Maldonado, M.I.; Campos-García, J.; Ortiz-Alvarado, R.; Jácome-Galarza, I.E.; Ramírez-Díaz, M.I.; et al. Control of morphology and virulence by ADP-ribosylation factors (Arf) in Mucor circinelloides. Curr. Genet. 2017, 64, 853–869.
  77. Patiño-Medina, J.A.; Reyes-Mares, N.Y.; Valle-Maldonado, M.I.; Jácome-Galarza, I.E.; Pérez-Arques, C.; Nuñez-Anita, R.E.; Campos-García, J.; Anaya-Martínez, V.; Ortiz-Alvarado, R.; Ramírez-Díaz, M.I.; et al. Heterotrimeric G-alpha subunits Gpa11 and Gpa12 define a transduction pathway that control spore size and virulence in Mucor circinelloides. PLoS ONE 2019, 14, e0226682.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Biochemistry & Molecular Biology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Francisco Esteban Nicolas Molina , Carlos Lax Molina , José Cánovas-Márquez , Ghizlane Tahiri , Eusebio Navarro Ros , Victoriano Garre
View Times: 609
Revisions: 2 times (View History)
Update Date: 02 Apr 2022
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback